LPL Financial’s INmune Bio INMB Stock Holding History

LPL Financial’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9K	Buy	+12,842	New	+$17.8K	﹤0.01%	6122
2025 Q3	–	Sell	-43,172	Closed	-$99.7K	–	5893
2025 Q2	$99.7K	Buy	+43,172	New	+$317K	﹤0.01%	5267
2025 Q1	–	Sell	-19,072	Closed	-$89.1K	–	5441
2024 Q4	$89.1K	Buy	19,072 +4,730	+33%	+$24.7K	﹤0.01%	5014
2024 Q3	$77.3K	Buy	14,342 +945	+7%	+$6.72K	﹤0.01%	4942
2024 Q2	$118K	Buy	13,397 +3,375	+34%	+$33.3K	﹤0.01%	4705
2024 Q1	$118K	Sell	10,022 -75	-0.7%	-$906	﹤0.01%	4644
2023 Q4	$114K	Hold	10,097	–	–	﹤0.01%	4526
2023 Q3	$68.4K	Buy	+10,097	New	+$83.7K	﹤0.01%	4479

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial's INMB Position: Q2 2026 in Review

LPL Financial opened a new position in INmune Bio (INMB) in Q2 2026: 12,842 shares worth $20.9K. The stake represents ﹤0.01% of the portfolio and ranks #6122 among its holdings. This is a return to the name: LPL Financial previously reported a position in INMB as recently as Q2 2025.

LPL Financial first reported a position in INMB in Q3 2023 and has held it in 8 quarters since. The position peaked at $118K in Q2 2024. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

LPL Financial held 12,842 shares of INmune Bio worth $20.9K as of Q2 2026.
INmune Bio was a new LPL Financial position in Q2 2026.
INmune Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6122 holding.
LPL Financial first reported a position in INmune Bio in Q3 2023 and has held it in 8 quarters since.
LPL Financial's INmune Bio position peaked at $118K in Q2 2024.
83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.